Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study
dc.contributor.author | Uguz, Faruk | |
dc.contributor.author | Kirkas, Aysegul | |
dc.date.accessioned | 2024-02-23T14:30:07Z | |
dc.date.available | 2024-02-23T14:30:07Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Objective: To examine whether olanzapine and quetiapine are useful in the prevention of a new mood episode during the postpartum period. Methods: Data on 23 patients (n=14 for olanzapine and n=9 for quetiapine) with bipolar disorder who met the criteria for this study were retrospectively gathered. The diagnosis of bipolar disorder was determined by means of the DSM-IV. Results: The mean follow-up period was 33.95 +/- 12.07 weeks. Six (26.1%) of 23 patients experienced recurrent mood episodes during the postpartum period. Four of these six patients were taking olanzapine and two were taking quetiapine. Patients with recurrent mood episodes had a significantly stronger family history of bipolar disorder, higher number of past episodes, and earlier onset and longer duration of illness compared to patients without recurrent mood episodes. Conclusion: Monotherapy with olanzapine or quetiapine can be considered as an alternative to mood stabilizers in preventing the development of new mood episodes after childbirth. | en_US |
dc.identifier.doi | 10.1590/1516-4446-2020-1629 | |
dc.identifier.endpage | 620 | en_US |
dc.identifier.issn | 1516-4446 | |
dc.identifier.issn | 1809-452X | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 33825764 | en_US |
dc.identifier.scopus | 2-s2.0-85122294074 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 617 | en_US |
dc.identifier.uri | https://doi.org/10.1590/1516-4446-2020-1629 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/15025 | |
dc.identifier.volume | 43 | en_US |
dc.identifier.wos | WOS:000760090300011 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Assoc Brasileira Psiquiatria | en_US |
dc.relation.ispartof | Brazilian Journal Of Psychiatry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Postpartum Period | en_US |
dc.subject | Olanzapine | en_US |
dc.subject | Quetiapine | en_US |
dc.subject | Bipolar Disorder | en_US |
dc.title | Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study | en_US |
dc.type | Article | en_US |